PEGylated Recombinant Factor VIII Recruiting Phase 4 Trials for Factor VIII (FVIII) / Hemophilia A Treatment

Indications	Status	Purpose	Phase
DBCOND0115671 (Factor VIII (FVIII)) DBCOND0001634 (Hemophilia A)	Recruiting	Treatment	4

clinicaltrials.gov Identifier	Title	Drugs
NCT04690322	POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies	Antihemophilic factor, human recombinant (DB00025) Efmoroctocog alfa (DB11607) Emicizumab (DB13923) PEGylated Recombinant Factor VIII (DB16093)